The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope-Reference-Cited by-同舟云学术

The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope

Published:2018-06-26 Issue:10 Volume:20 Page:1404-1412
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Al-Saaidi Rasha A.¹,Rasmussen Torsten B.²,Birkler Rune I.D.¹,Palmfeldt Johan¹,Beqqali Abdelaziz³,Pinto Yigal M.⁴,Nissen Peter H.⁵,Baandrup Ulrik⁶,Mølgaard Henning²,Hey Thomas M.⁷,Eiskjaer Hans²,Bross Peter¹,Mogensen Jens⁷

Affiliation:

1. Research Unit for Molecular Medicine; Aarhus University and University Hospital; Aarhus Denmark

2. Department of Cardiology; Aarhus University Hospital; Aarhus Denmark

3. Centre for Cardiovascular Science; University of Edinburgh; Edinburgh UK

4. Heart Failure Research Center; Academic Medical Center; Amsterdam The Netherlands

5. Department of Clinical Biochemistry; Aarhus University Hospital; Aarhus Denmark

6. Centre for Clinical Research, North Denmark Regional Hospital/Department of Clinical Medicine; Aalborg University; Aalborg Denmark

7. Department of Cardiology; Odense University Hospital; Odense Denmark

Funder

EU Seventh Framework Programme

Faculty of Health Sciences, Aarhus University

John and Birthe Meyer Foundation

Lundbeck Foundation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.1241/fullpdf

Reference28 articles.

1. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease;Fatkin;N Engl J Med,1999

2. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy;Bonne;Nat Genet,1999

3. Primary prevention of sudden death in patients with lamin A/C gene mutations;Meune;N Engl J Med,2006

4. Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study;Rijsingen;J Am Coll Cardiol,2012

5. Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers;Kumar;J Am Coll Cardiol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration;BMC Medical Genomics;2023-10-02

2. Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA;Revista Española de Cardiología;2021-03

3. Medicina de precisión aplicada a laminopatías: enseñanzas del registro REDLAMINA;Revista Española de Cardiología;2021-03

4. Precision medicine in laminopathies: insights from the REDLAMINA registry;Revista Española de Cardiología (English Edition);2021-03

5. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry;Revista Española de Cardiología (English Edition);2021-03